Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Device Week Coronavirus COVID-19 Diversity & Inclusion

Device Week, 21 October 2021 – Post-Pandemic Perspectives; Good And Bad News For Medtronic

  • Analysis

Executive Summary

In this edition of Device Week, Medtech Insight’s Reed Miller discusses some important news from Medtronic and Marion Webb reviews the first of two feature articles on the impact of the pandemic on the medtech industry around the world.

Listen to the podcast via the player below:

 

The archive of Device Week and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn, Spotify Podcasts and via smart speakers if one of these platforms has been set up as your default podcast provider.

Medtech Insight articles addressing topics discussed in this episode:

Market Intel: Lessons Learned From COVID-19: A Global Perspective On Digital Health Transformation

Medtronic Pushes Completion Of Pivotal Renal Denervation Trial To Late 2022

Medtronic ‘Refreshes Brand,’ Announces New Environmental, Social, and Governance Targets

     

    Table

    View full table

    Topics

    Tags:
    Device Week Coronavirus COVID-19 Diversity & Inclusion
    Latest Headlines

    GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

    FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

    ‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

    Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

    See All
    UsernamePublicRestriction

    Register

    MT144613

    Ask The Analyst

    Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

    Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

    All fields are required.

    Please make sure all fields are completed.

    Please make sure you have filled out all fields

    Please make sure you have filled out all fields

    Please enter a valid e-mail address

    Please enter a valid Phone Number

    Ask your question to our analysts

    Cancel

    This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

    Printed By